Med-IQ
Duke Perspectives on Atrial Fibrillation from the 2021 American Heart Association Annual Meeting

Duke Perspectives on Atrial Fibrillation from the 2021 American Heart Association Annual Meeting

PDF Publication
Online Course | Specialties: Cardiology
Released: 12/14/2021
|
Expires: 6/13/2022
|
Max Credits: 0.5
Jump to Education

Faculty
Jonathan P. Piccini, MD, MHS
Associate Professor of Medicine
Director, Cardiac Electrophysiology
Duke University School of Medicine
Durham, NC

Activity Planners
Julie Blum, PhD
Director, Clinical Content
Med-IQ
Baltimore, MD
 
Lisa R. Rinehart, MS, ELS
Director, Editorial Services
Med-IQ
Baltimore, MD
 
Samantha Gordon, MS
Accreditation Manager
Med-IQ
Baltimore, MD
 
Amy Sison
Director of CME
Med-IQ
Baltimore, MD

Writer
Katherine Kahn
Holyoke, MA
 
Learning Objective
Upon completion, participants should be able to:

  • Discuss pertinent new studies presented at AHA and consider how to apply this information to clinical practice

Target Audience
This activity is intended for cardiologists
 
Statement of Need
More than 90 presentations were shared by faculty members, residents, and fellows from the Duke University School of Medicine, Department of Cardiology, at the 2021 AHA Annual Meeting. Herein, we summarize information from select presentations and provide expert insight from Jonathan Piccini, MD, MHS, associate professor of medicine and director of the Cardiac Electrophysiology section at the Duke Heart Center, with the goal of helping local and community cardiologists and internists stay abreast of current clinical research taking place at Duke Cardiology.

Collaboration Statement
This activity was developed by Med-IQ in collaboration with Duke Health.


Accreditation Statement
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Med-IQ designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Medium/Method of Participation
This CE activity consists of a 0.5-credit online publication. To receive credit, read the introductory CE material, read the publication, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly. 

Initial Release Date: December 14, 2021
Expiration Date: June 13, 2022
Estimated Time to Complete This Activity: 30 minutes

Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 24 months that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.

Disclosure Statement
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation. 

Jonathan P. Piccini, MD, MHS
Contracted research: Abbott, Ablacon, AbbVie Inc., AltaThera, ARCA Biopharma, Bayer HealthCare Pharmaceuticals, BIOTRONIK, Boston Scientific Corporation, Bristol-Myers Squibb, ElectroPhysiology Frontiers, iRhythm Technologies, Inc., LivaNova, Medtronic Inc., Milestone Pharmaceuticals, Pfizer, Inc., Phillips Pharma Group, Sanofi-aventis U.S., Inc.

The writer, peer reviewers, and activity planners have no financial relationships to disclose.

Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, Med-IQ has a policy to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.

Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.

Contact Information       
For questions or comments about this activity, please contact Med-IQ.
Call (toll-free) 866 858 7434 or e-mail info@med-iq.com.

System Requirements


Desktop


Mobile

  • Operating system - Med-IQ supports the current operating system, plus two prior releases:
    • Android (eg, Samsung Galaxy)
    • Apple (eg, iPhone/iPad)
  • Browsers - Med-IQ supports the default browser for the applicable operating system release, plus two prior releases:
    • Android (Chrome)
    • Apple (Safari)


Applications & Software

For technical assistance, please refer to our Support Manual.
 
Disclaimer

The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy notice, please visit: www.med-iq.com/privacy-statement/.

Copyright
© 2021 Duke University Health System 

Abstract

Developed in collaboration

Here are the key takeaways from this activity. Deeper insights and evidence, plus an opportunity to receive credit, are available at the "Continue" button below.

  • The PALACS study found that the performance of a posterior left pericardiectomy in patients undergoing common types of cardiac surgery was associated with a large and highly statistically significant reduction in the risk of postoperative AF1
  • The aMAZE trial demonstrated that an adjunctive LARIAT procedure was not superior to PVAI alone but appears to be safe and successfully excludes the left atrial appendage2
  • The I-STOP-AFib trial showed that “custom” patient-identified triggers were the most likely to be associated with episodes of AF, which highlights how individual patients are the best experts on what triggers their own arrhythmia3
  • The GIRAF trial is the first prospective study to compare outcomes between warfarin and dabigatran; researchers found no difference in MMSE, NTB, and CGNT scores between the dabigatran and warfarin groups but did observe a statistically significant difference in MoCA scores in favor of warfarin4
  • A retrospective observational study using administrative claims data from nearly 45,000 individuals enrolled in Medicare demonstrated that only a minority of patients with AF and cancer receive oral anticoagulation5
  • A study exploring the importance of different AF symptoms to patients used the Toronto AFSS and demonstrated that patient expectations for successful AF management differ from current clinical AF treatment targets6
  • Health disparities are linked with social, economic, and environmental disadvantage but are also often associated with demographics that can include race; the ramifications of various types of racism are clearly seen in arrhythmia management7

View reference list.

Click “Continue” to proceed through this activity and/or receive credit. 

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

COPYRIGHTED. Republication or redistribution of Med‑IQ content, including by framing, is prohibited without prior written consent. Med‑IQ shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.